These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10630462)

  • 1. Does guanfacine cause hallucinations in children?
    Luthra V; Markov D; Ambrosini P
    J Child Adolesc Psychopharmacol; 1999; 9(4):313-4. PubMed ID: 10630462
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychosis associated with guanfacine.
    Kim RK; Chayer R
    J Clin Psychopharmacol; 2015 Apr; 35(2):213. PubMed ID: 25679136
    [No Abstract]   [Full Text] [Related]  

  • 3. Does guanfacine trigger mania in children?
    Horrigan JP; Barnhill LJ
    J Child Adolesc Psychopharmacol; 1998; 8(2):149-50. PubMed ID: 9730081
    [No Abstract]   [Full Text] [Related]  

  • 4. Hallucinations associated with initiation of guanfacine.
    Boreman CD; Arnold LE
    J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1387. PubMed ID: 14627872
    [No Abstract]   [Full Text] [Related]  

  • 5. Guanfacine for Tourette's disorder.
    Fras I
    J Am Acad Child Adolesc Psychiatry; 1996 Jan; 35(1):3-4. PubMed ID: 8567607
    [No Abstract]   [Full Text] [Related]  

  • 6. Seizure after guanfacine plus bupropion: correction.
    Tilton P
    J Am Acad Child Adolesc Psychiatry; 2000 Nov; 39(11):1341. PubMed ID: 11068884
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased plasma valproate concentrations when coadministered with guanfacine.
    Ambrosini PJ; Sheikh RM
    J Child Adolesc Psychopharmacol; 1998; 8(2):143-7. PubMed ID: 9730080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone response to guanfacine in boys with attention deficit hyperactivity disorder: a preliminary study.
    Halperin JM; Newcorn JH; McKay KE; Siever LJ; Sharma V
    J Child Adolesc Psychopharmacol; 2003; 13(3):283-94. PubMed ID: 14642016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case series on the heightened autonomic response due to guanfacine and amphetamine interaction.
    Gaiser EC; Matuskey D; Perkins E; D'Amico C; Abdelghany O; McKee SA; Cosgrove KP
    J Clin Psychopharmacol; 2015 Apr; 35(2):197-9. PubMed ID: 25634160
    [No Abstract]   [Full Text] [Related]  

  • 10. Guanfacine use in children with attention deficit hyperactivity disorder.
    Cohn LM; Caliendo GC
    Ann Pharmacother; 1997; 31(7-8):918-9. PubMed ID: 9220058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment.
    Neylan TC; Lenoci M; Samuelson KW; Metzler TJ; Henn-Haase C; Hierholzer RW; Lindley SE; Otte C; Schoenfeld FB; Yesavage JA; Marmar CR
    Am J Psychiatry; 2006 Dec; 163(12):2186-8. PubMed ID: 17151174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder.
    Boellner SW; Pennick M; Fiske K; Lyne A; Shojaei A
    Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanfacine in children with autism and/or intellectual disabilities.
    Handen BL; Sahl R; Hardan AY
    J Dev Behav Pediatr; 2008 Aug; 29(4):303-8. PubMed ID: 18552703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clonidine hallucinations: description of a clinical case].
    Campanella C; Salvini S; Casaldi S; Chiacchiararelli F; Serra A; Di Giacomo G
    Clin Ter; 2000; 151(1):45-7. PubMed ID: 10822881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases.
    Posey DJ; Puntney JI; Sasher TM; Kem DL; McDougle CJ
    J Child Adolesc Psychopharmacol; 2004; 14(2):233-41. PubMed ID: 15319020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder.
    Wilens TE; Bukstein O; Brams M; Cutler AJ; Childress A; Rugino T; Lyne A; Grannis K; Youcha S
    J Am Acad Child Adolesc Psychiatry; 2012 Jan; 51(1):74-85.e2. PubMed ID: 22176941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charles Bonnet syndrome and brimonidine: comments.
    Rahman I; Fernando B; Harrison M
    Br J Ophthalmol; 2004 May; 88(5):724. PubMed ID: 15090439
    [No Abstract]   [Full Text] [Related]  

  • 18. Guanfacine, but not clonidine, improves planning and working memory performance in humans.
    Jäkälä P; Riekkinen M; Sirviö J; Koivisto E; Kejonen K; Vanhanen M; Riekkinen P
    Neuropsychopharmacology; 1999 May; 20(5):460-70. PubMed ID: 10192826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of extended-release guanfacine on ADHD symptoms and sedation-related adverse events in children with ADHD.
    Faraone SV; Glatt SJ
    J Atten Disord; 2010 Mar; 13(5):532-8. PubMed ID: 19395648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial.
    Sallee FR; McGough J; Wigal T; Donahue J; Lyne A; Biederman J;
    J Am Acad Child Adolesc Psychiatry; 2009 Feb; 48(2):155-65. PubMed ID: 19106767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.